Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2925 of 3546 entries
View as:

Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00320359 Org: User:
Start: 08/31/02 End: 02/28/07 Due: 02/28/08

Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00111787 Org: User:
Start: 04/11/05 End: 11/01/06 Due: 11/01/07

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Phase: N/A Priority: Normal
NCT ID: NCT00368303 Org: User:
Start: 12/31/06 End: - Due: -

A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01818024 Org: User:
Start: 02/22/13 End: 10/25/13 Due: 10/25/14

Oral Tolerability Of Two Nicotine Dosage Forms

Phase: N/A Priority: Normal
NCT ID: NCT00682461 Org: User:
Start: 09/30/07 End: 01/31/09 Due: 01/31/10

SAP Depleter Dose Assessment Study in Patients

Phase: N/A Priority: Normal
NCT ID: NCT01406314 Org: User:
Start: 10/13/11 End: 11/14/12 Due: 11/14/13

Belimumab Assessment of Safety in SLE

Phase: N/A Priority: Normal
NCT ID: NCT01705977 Org: User:
Start: 11/27/12 End: 08/10/22 Due: 08/10/23

Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02045849 Org: User:
Start: 01/28/14 End: 08/21/14 Due: 08/21/15

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT00294047 Org: User:
Start: 02/16/06 End: 01/29/14 Due: 01/29/15

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

Phase: N/A Priority: Normal
NCT ID: NCT00659191 Org: User:
Start: 02/29/08 End: 11/30/08 Due: 11/30/09

Drug Use Investigation for PAXIL Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01371435 Org: User:
Start: 04/30/01 End: 12/31/05 Due: 12/31/06

Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children

Phase: N/A Priority: Normal
NCT ID: NCT02428127 Org: User:
Start: 05/01/15 End: 05/30/15 Due: 05/30/16

A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children

Phase: N/A Priority: Normal
NCT ID: NCT02551627 Org: User:
Start: 06/01/16 End: 10/01/17 Due: 10/01/18

Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT01480245 Org: User:
Start: 09/30/11 End: 03/31/14 Due: 03/31/15

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Phase: N/A Priority: Normal
NCT ID: NCT01562444 Org: User:
Start: 03/08/12 End: 09/30/16 Due: 09/30/17

A Study to Compare Two Paracetamol Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01381640 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00985790 Org: User:
Start: 10/08/09 End: 05/21/10 Due: 05/21/11

Drug Use Investigation for HEPSERA (Adefovir) Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01863589 Org: User:
Start: 02/28/05 End: 07/31/12 Due: 07/31/13

An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00695305 Org: User:
Start: 11/30/08 End: 05/31/10 Due: 05/31/11

Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00443131 Org: User:
Start: 03/26/07 End: 07/13/07 Due: 07/13/08

A Healthy Volunteer Study With Inhaled GSK573719 and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00803673 Org: User:
Start: 05/05/08 End: 10/16/08 Due: 10/16/09

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

Phase: N/A Priority: Normal
NCT ID: NCT03298061 Org: User:
Start: 04/14/15 End: 02/16/23 Due: 02/16/24

Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC

Phase: N/A Priority: Normal
NCT ID: NCT01138046 Org: User:
Start: 04/30/10 End: 01/31/14 Due: 01/31/15

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00405392 Org: User:
Start: 03/22/07 End: 05/27/08 Due: 05/27/09

Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705

Phase: N/A Priority: Normal
NCT ID: NCT00500461 Org: User:
Start: 06/04/07 End: 07/25/07 Due: 07/25/08